Basit öğe kaydını göster

dc.contributor.authorJIANG, NY
dc.contributor.authorERTAN, A
dc.contributor.authorBAYLOR, LM
dc.contributor.authorCOY, DH
dc.contributor.authorOZMEN, Vahit
dc.contributor.authorROSSOWSKI, WJ
dc.contributor.authorZACHARIA, S
dc.contributor.authorMUNGAN, Z
dc.date.accessioned2021-03-04T13:39:12Z
dc.date.available2021-03-04T13:39:12Z
dc.date.issued1992
dc.identifier.citationROSSOWSKI W., ZACHARIA S., MUNGAN Z., OZMEN V., ERTAN A., BAYLOR L., JIANG N., COY D., "REDUCED GASTRIC-ACID INHIBITORY EFFECT OF A PGIP(1-30)NH2 FRAGMENT WITH POTENT PANCREATIC AMYLASE INHIBITORY ACTIVITY", REGULATORY PEPTIDES, cilt.39, sa.1, ss.9-17, 1992
dc.identifier.issn0167-0115
dc.identifier.othervv_1032021
dc.identifier.otherav_7d89d783-5794-44c8-95f4-52beaaca0977
dc.identifier.urihttp://hdl.handle.net/20.500.12627/85761
dc.identifier.urihttps://doi.org/10.1016/0167-0115(92)90003-d
dc.description.abstractGastric inhibitory polypeptide (GIP) strongly stimulates insulin secretion in the presence of glucose and also stimulates somatostatin release from gastric mucosa. It was reported recently that both stimulatory activities can be dissociated by removing the C-terminal 12 amino acid residues. Since insulin and somatostatin are involved in regulation of exocrine pancreatic and gastric secretion in rats, we compared the inhibitory effects of pGIP and the pGIP(1-30)NH2 fragment on pancreatic amylase and gastric acid secretion. pGIP(1-30)NH2 displayed full activity on inhibition of bombesin (BN)-stimulated amylase release relative to GIP itself, but was about 10-fold less potent in inhibiting gastric acid secretion. These results suggest that the receptors involved in these two events have quite different ligand binding requirements and that more specific analogues of GIP can be designed which should be of value in elucidating the physiological roles of this hormone.
dc.language.isoeng
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyokimya
dc.subjectFizyoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectBiyoloji ve Biyokimya
dc.subjectFİZYOLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.titleREDUCED GASTRIC-ACID INHIBITORY EFFECT OF A PGIP(1-30)NH2 FRAGMENT WITH POTENT PANCREATIC AMYLASE INHIBITORY ACTIVITY
dc.typeMakale
dc.relation.journalREGULATORY PEPTIDES
dc.contributor.department, ,
dc.identifier.volume39
dc.identifier.issue1
dc.identifier.startpage9
dc.identifier.endpage17
dc.contributor.firstauthorID16867


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster